"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...
DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...
Even with the same cancer diagnosis personalised treatments are essential due to variations in patient health cancer ...
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...
Susan G. Komen: Quality of Life After Breast Cancer Treatment. National Cancer Institute: Complementary and Alternative ...
Alarming rates of secondary breast cancer are on the rise, with the figure increasing year on year since 2018 so it's more important than ever to know where it is most likely to occur and what to look ...
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...